国际顶刊文献统计平台

$2.5M Department of Defense grant funds triple-negative breast cancer therapies $2.5M Department of Defense grant funds triple-negative breast cancer therapies

Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.